Results
14
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
14 companies
Kamada
Market Cap: ₪1.3b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪23.38
7D
4.7%
1Y
19.3%
G.F.C Green Fields Capital
Market Cap: ₪121.5m
Does not have significant operations.
GFC-M
₪12.10
7D
0%
1Y
11.0%
HBL - Hadasit Bio-Holdings
Market Cap: ₪4.5m
Operates in the biotechnology industry in Israel.
HDST-M
₪0.41
7D
0%
1Y
-22.6%
BioLight Life Sciences
Market Cap: ₪29.0m
An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.
BOLT
₪6.24
7D
-0.9%
1Y
71.9%
PlantArc Bio
Market Cap: ₪7.5m
Operates as an Ag-Bio company for the crop protection and yield enhancement.
PLNT
₪2.26
7D
-2.7%
1Y
-16.5%
Seach Medical Group
Market Cap: ₪93.5m
Manufactures and sells medicinal cannabis products worldwide.
SEMG
₪2.83
7D
15.9%
1Y
82.1%
Smart Agro -
Market Cap: ₪10.7m
Focuses on the research and development in the field of agricultural technology in Israel.
SMAG
₪2.55
7D
-6.6%
1Y
n/a
Purple Biotech
Market Cap: ₪26.0m
A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.
PPBT
₪0.049
7D
4.3%
1Y
-78.8%
Evogene
Market Cap: ₪24.8m
Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.
EVGN
₪3.80
7D
-8.4%
1Y
-86.2%
Matricelf
Market Cap: ₪49.0m
A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.
MTLF
₪3.03
7D
7.8%
1Y
-33.1%
Grace Breeding
Market Cap: ₪75.0m
An agro-tech company, develops nitrogenous and climate change stress relief products in Europe, the United States, South America, and Israel.
GRAC
₪18.47
7D
-0.05%
1Y
66.4%
BioLineRx
Market Cap: ₪38.0m
A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
BLRX
₪0.017
7D
0%
1Y
-90.6%
Can-Fite BioPharma
Market Cap: ₪59.0m
A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.
CANF
₪0.019
7D
5.6%
1Y
-32.1%
Rekah Pharmaceutical Industry
Market Cap: ₪132.0m
Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.
REKA
₪11.56
7D
-2.9%
1Y
-20.2%